168 related articles for article (PubMed ID: 22889869)
1. Molecular diagnosis in HAP/VAP.
Lung M; Codina G
Curr Opin Crit Care; 2012 Oct; 18(5):487-94. PubMed ID: 22889869
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Barbier F; Andremont A; Wolff M; Bouadma L
Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
[TBL] [Abstract][Full Text] [Related]
4. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance.
Enne VI; Personne Y; Grgic L; Gant V; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):252-8. PubMed ID: 24614243
[TBL] [Abstract][Full Text] [Related]
5. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
Bassetti M; Taramasso L; Giacobbe DR; Pelosi P
Expert Rev Anti Infect Ther; 2012 May; 10(5):585-96. PubMed ID: 22702322
[TBL] [Abstract][Full Text] [Related]
6. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
[TBL] [Abstract][Full Text] [Related]
7. The microbiology of ventilator-associated pneumonia.
Park DR
Respir Care; 2005 Jun; 50(6):742-63; discussion 763-5. PubMed ID: 15913466
[TBL] [Abstract][Full Text] [Related]
8. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
9. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
[TBL] [Abstract][Full Text] [Related]
10. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
Bradley JS
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
[TBL] [Abstract][Full Text] [Related]
11. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
Sandiumenge A; Rello J
Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
[TBL] [Abstract][Full Text] [Related]
12. Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group.
Song JH;
Am J Infect Control; 2008 May; 36(4 Suppl):S83-92. PubMed ID: 18468550
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units.
Koulenti D; Lisboa T; Brun-Buisson C; Krueger W; Macor A; Sole-Violan J; Diaz E; Topeli A; DeWaele J; Carneiro A; Martin-Loeches I; Armaganidis A; Rello J;
Crit Care Med; 2009 Aug; 37(8):2360-8. PubMed ID: 19531951
[TBL] [Abstract][Full Text] [Related]
14. Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.
Iregui MG; Kollef MH
Semin Respir Crit Care Med; 2001 Jun; 22(3):317-26. PubMed ID: 16088683
[TBL] [Abstract][Full Text] [Related]
15. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia.
Luyt CE; Hékimian G; Koulenti D; Chastre J
Curr Opin Crit Care; 2018 Oct; 24(5):332-338. PubMed ID: 30036192
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
18. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries.
Chawla R
Am J Infect Control; 2008 May; 36(4 Suppl):S93-100. PubMed ID: 18468551
[TBL] [Abstract][Full Text] [Related]
20. Incidence, etiology, and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in istanbul, Turkey (2004-2006).
Erdem I; Ozgultekin A; Inan AS; Dincer E; Turan G; Ceran N; Ozturk Engin D; Senbayrak Akcay S; Akgun N; Goktas P
Jpn J Infect Dis; 2008 Sep; 61(5):339-42. PubMed ID: 18806338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
